North Carolina – Talk Bio

Ypsomed Invests $248 Million to Establish First U.S. Manufacturing Site in North Carolina

4 days ago talkbio0Tagged CHF, expansion, Facility (object), global growth strategy, Holly Springs, Manufacturing, medical technology, North Carolina, self-injection systems, Surgical construction, United States, Ypsomed

Ypsomed; manufacturing expansion; U.S. facility; Holly Springs; North Carolina; CHF 200 million; self-injection systems; job creation; global growth strategy; medical technology

Vaxcyte Strikes up to $1B Fill-Finish Manufacturing Deal with Thermo Fisher at North Carolina Facility

2 weeks ago talkbio0Tagged biomanufacturing, commercial supply chain, Manufacturing, North Carolina, PCVs, pneumococcal conjugate vaccines, production, Thermo Fisher Scientific, United States, Vaccines, VAX-24, VAX-31, Vaxcyte

Vaxcyte; Thermo Fisher Scientific; fill-finish manufacturing; North Carolina; pneumococcal conjugate vaccines; PCVs; VAX-31; VAX-24; commercial supply chain; biomanufacturing; U.S. vaccine production; $1 billion deal

Catalent Opens New Global HQ; Fujifilm Launches North Carolina Factory

3 weeks ago talkbio0Tagged Biopharma, Catalent, Cell Culture Techniques, Fujifilm Biotechnologies, global headquarters, Holly Springs, Johnson and Johnson, Manufacturing Facilities, North Carolina, Tampa Florida

Catalent; Global Headquarters; Tampa Florida; Fujifilm Biotechnologies; North Carolina; Holly Springs; manufacturing facility; Johnson & Johnson; cell culture; biopharma

Genentech’s $700M North Carolina Plant and Telix’s FDA CRL Update

2 months ago talkbio0Tagged biomanufacturing, Complete Response Letter, CRL, genentech, Holly Springs, Manufacturing Facilities, Medicinal product acting as imaging agent (product), metabolic medicines, North Carolina, Obesity, Roche (company), Telix, United States Food and Drug Administration

Genentech; Roche; North Carolina; manufacturing facility; $700 million; Holly Springs; metabolic medicines; obesity treatments; biomanufacturing; Telix; FDA; Complete Response Letter (CRL); imaging agent

Johnson & Johnson Commits $2B to Fujifilm North Carolina Site in Latest US Manufacturing Push

2 months ago talkbio0Tagged Billion, Biopharma, Fujifilm, Investments, Johnson and Johnson, Manufacturing, North Carolina, Surgical construction, U.S.

Johnson & Johnson; Fujifilm; manufacturing; North Carolina; $2 billion investment; biopharma; job creation; US manufacturing

Biogen Pledges $2 Billion Manufacturing Investment in North Carolina

3 months ago talkbio0Tagged Antisense Oligonucleotides, Artificial Intelligence, Automation, Biogen, Biotechnology, expansion, gene therapy, Investments, Manufacturing, North Carolina, Research Triangle Park

Biogen; manufacturing investment; North Carolina; Research Triangle Park; biotechnology; antisense oligonucleotides; gene therapy; automation; AI; expansion

Merck opens $1B Gardasil manufacturing facility in North Carolina

7 months ago talkbio0Tagged Durham, Facility (object), Manufacture, Merck, North Carolina

Merck, Facility (object), Manufacture, Durham, North Carolina

Merck Opens $1 Billion Vaccine Manufacturing Facility in North Carolina

7 months ago talkbio0Tagged Drug Industry, Durham, Gardasil, HPV vaccine, Manufacturing, Merck, North Carolina, U.S., Vaccines

Merck, vaccine manufacturing, Durham, North Carolina, Gardasil, HPV vaccine, pharmaceutical industry, US manufacturing

Charles River Laboratories Closing Durham Facility, Laying Off 31 Employees

9 months ago talkbio0Tagged Charles, Contract Research Organization, Durham, Facility (object), North Carolina, Pharmaceutical Research, Reparative closure, restructuring, River Laboratories

Charles River Laboratories, Durham, North Carolina, facility closure, layoffs, pharmaceutical research, contract research organization, restructuring

National Resilience Lays Off 120 Employees at Former Bluebird Bio Gene Therapy Facility in Durham, North Carolina

9 months ago talkbio0Tagged Bio, biotech industry, CDMO, Contract Development, Durham/, Family Turdidae (organism), gene therapy, layoffs, Manufacturing Organization, National Resilience, North Carolina

National Resilience, Layoffs, Gene Therapy, Bluebird Bio, Durham/ North Carolina, Biotech Industry, CDMO (Contract Development and Manufacturing Organization)